Diabetes

Diabetes can trigger a cascading series of medical complications. ERG has conducted early- and late-phase studies across a broad range of diabetes-driven issues from diabetic eye disease and renal disease to diabetes-related dementia, nerve damage, and cardiac and blood pressure concerns, as well as lipid and glycemic studies.

ERG’s multi-faceted group of expert clinicians attack diabetes research from many different angles including neurology, physical medicine, rehabilitation and amputee medicine, pain, and the psychiatry of chronic illness. Bringing both innovation and forethought to diabetes clinical research design and planning, they are thoroughly invested in ensuring that the work we do from protocol design to implementation is of superior quality.

ERG Expert Diabetes Team
Jim Aukstuolis, MD
Juan Carlos Rondon, MD
Robert Billingsley, Jr., MD
Gerald Cephas, MD
Otto Dueno, MD
Steven Folkerth, MD
Daniel Gruener, MD
George Konis, MD
Kenneth Lasseter, MD
Samuel Oberstein, MD
Thomas Reilly, MD
Hernan Salazar, MD
Sherwyn Schwartz, MD
Stephen Thein, PhD

Affiliate Diabetes Team
Paul Miller, MD

ERG has over 5,300 patients with diabetes in our current database, with profiles including: Diabetes Diagnosis, Metformin with Diagnosis, Metformin without Diagnosis, Insulin with Diagnosis, Insulin without Diagnosis, DPP-4 Inhibitors with Diagnosis, and DPP-4 Inhibitors without Diagnosis. As we screen patients, we examine liver and kidney function as well as A1C and microalbumin.